semaglutide bone mass New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on Type 2 diabetes: Semaglutide may

Adequate protein intake mitigates this concern

But animal studies do not always reflect what will happen in humans

I knew at that time that something had to be done to preserve this legendary landmark

So, lets look at two prominent weight loss drugs so you can make the best decision for your journey

If you are still experiencing significant nausea, diarrhea, or vomiting at the end of a 4-week period, stay at the current dose for another 2-4 weeks

Eli Lillys CEO Dave Ricks has positioned Foundayo as a gateway option for people hesitant to start GLP-1 therapy, as well as a maintenance option for patients whove achieved their goal weight on an injectable